Chad Messer
Stock Analyst at Lake Street
(0.70)
# 4,013
Out of 5,005 analysts
28
Total ratings
39.29%
Success rate
-17.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $99.39 | +6.65% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.31 | +1,312.43% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $1.38 | +407.25% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.10 | +162.29% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $4.11 | +508.27% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $12.38 | +85.78% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $2.02 | +840.59% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.30 | +3,354.55% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $50.51 | -1.01% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $56.97 | -15.75% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $40.09 | -25.17% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $47.00 | +6.38% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $11.34 | +155.73% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.04 | +390.20% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $69.15 | +24.37% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $4.32 | +1,636.11% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $9.38 | +369.08% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $22.64 | +633.22% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $2.83 | +536.04% | 1 | May 5, 2020 |
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $99.39
Upside: +6.65%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.31
Upside: +1,312.43%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.38
Upside: +407.25%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.10
Upside: +162.29%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $4.11
Upside: +508.27%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $12.38
Upside: +85.78%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $2.02
Upside: +840.59%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.30
Upside: +3,354.55%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $50.51
Upside: -1.01%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $56.97
Upside: -15.75%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $40.09
Upside: -25.17%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $47.00
Upside: +6.38%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $11.34
Upside: +155.73%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.04
Upside: +390.20%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $69.15
Upside: +24.37%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $4.32
Upside: +1,636.11%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $9.38
Upside: +369.08%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $22.64
Upside: +633.22%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $2.83
Upside: +536.04%